UiPath (NYSE:PATH) Trading 0.5% Higher

Shares of UiPath Inc. (NYSE:PATH) rose 0.5% during mid-day trading on Friday . The company traded as high as $19.75 and last traded at $19.50. Approximately 1,296,716 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 8,657,022 shares. The stock had previously closed at $19.41.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Barclays lifted their price objective on UiPath from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Friday, March 15th. Evercore ISI upped their price objective on shares of UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a report on Thursday, March 14th. Morgan Stanley lifted their target price on shares of UiPath from $17.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, March 14th. Canaccord Genuity Group increased their price target on shares of UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, March 15th. Finally, Mizuho lifted their price target on shares of UiPath from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to MarketBeat.com, UiPath currently has a consensus rating of “Moderate Buy” and an average target price of $27.41.

UiPath Stock Up 0.3 %

The firm has a market cap of $11.07 billion, a price-to-earnings ratio of -114.70 and a beta of 0.96. The company’s 50-day moving average price is $22.30 and its 200-day moving average price is $21.53.

UiPath (NYSE:PATH) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The company had revenue of $405.25 million for the quarter, compared to analyst estimates of $383.32 million. On average, sell-side analysts predict that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insider Activity at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of UiPath stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the completion of the sale, the chief financial officer now directly owns 87,505 shares of the company’s stock, valued at approximately $1,998,614.20. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Over the last three months, insiders sold 72,000 shares of company stock worth $1,591,360. Company insiders own 31.03% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Mark Sheptoff Financial Planning LLC purchased a new position in shares of UiPath in the 4th quarter valued at $25,000. HighMark Wealth Management LLC acquired a new position in UiPath during the fourth quarter worth approximately $27,000. Cypress Capital Management LLC WY purchased a new stake in UiPath in the fourth quarter valued at approximately $29,000. Fifth Third Bancorp boosted its holdings in shares of UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after acquiring an additional 1,905 shares during the period. Finally, GAMMA Investing LLC purchased a new position in shares of UiPath during the fourth quarter worth approximately $36,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.